High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients. Gladstone DE, Golightly MG, Brannagan TH J Neuroimmunol. 2007 Oct; 190(1-2):121-6. Epub 2007 Sep 14. PMID: 17854912. Abstract CommentRecommendBookmarkWatch